Economic costs and preference-based health-related quality of life outcomes associated with childhood psychiatric disorders

British Journal of Psychiatry

Volumn 197, Issue 5, 2010, Pages 395-404

  Petrou, Stavros ^a   Johnson, Samantha ^b   Wolke, Dieter ^c   Hollis, Chris ^d   Kochhar, Puja ^d   Marlow, Neil ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHILDHOOD DISEASE; COST OF ILLNESS; ECONOMIC EVALUATION; EDUCATION; FEMALE; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OUTCOMES RESEARCH; POPULATION RESEARCH; PREMATURITY; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL WORK; TERM BIRTH;

ADOLESCENT; ADULT; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; AUTISTIC DISORDER; CHILD; CHILD BEHAVIOR DISORDERS; CHILD, PRESCHOOL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; FEMALE; GESTATIONAL AGE; GREAT BRITAIN; HEALTH CARE COSTS; HEALTH SERVICES; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MENTAL DISORDERS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREGNANCY; PREMATURE BIRTH; QUALITY OF LIFE; QUESTIONNAIRES; STATE MEDICINE; STATISTICS AS TOPIC;

EID: 78249239806     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.110.081307     Document Type: Article

References (64)

1. Roberts R. Prevalence of psychopathology among children and adolescents. Am J Psychiatry 1998; 155: 715-25.
2. Meltzer H, Gatward R, Goodman R, Ford T. Mental health of children and adolescents in Great Britain. Int Rev Psychiatry 2003; 15: 185-7.
3. Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 2003; 60: 837-44.
4. Kovacs M, Feinberg TL, Crouse-Novak M, Palauskas SL, Finkelstein R. Depressive disorders in childhood: I. A longitudinal prospective study of characteristics and recovery. Arch Gen Psychiatry 1984; 41: 229-37.
5. Kovacs M, Feinberg TL, Crouse-Novak M, Palauskas SL, Pollack M, Finkelstein R. Depressive disorders in childhood: II. A longitudinal study of the risk for a subsequent major depression. Arch Gen Psychiatry 1984; 41: 643-9.
6. Weiss G, Hechtman L, Milroy T, Perlman T. Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry 1985; 24: 211-20.
7. Lambert N. Adolescent outcomes for hyperactive children. Am Psychol 1988; 43: 786-99.
8. Keller MB, Lavori PW, Wunder J, Beardslee WR, Schwartz CE, Roth J. Chronic course of anxiety disorders in children and adolescents. J Am Acad Child Psychiatry 1992; 31: 595-99.
9. Cohen P, Cohen J, Brook J. An epidemiological study of disorders in late childhood and adolescence: II. Persistence of disorders. J Child Psychol Psychiatry 1993; 34: 869-77.
10. Cohen P, Cohen J, Kasen S, Velez CN, Hartmarh C, Johnson J, et al. An epidemiological study of disorders in late childhood and adolescence: I. Age- and gender-specific prevalence. J Child Psychol Psychiatry 1993; 34: 851-67.
11. Fergusson DM, Horwood LJ, Lynskey MT. Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15 year olds. J Am Acad Child Psychiatry 1993; 32: 1127-34.
12. Loeber R, Green S, Keenan K, Lahey BB. Which boys will fare worse? Early predictors of the onset of conduct disorder in a six-year longitudinal study. J Am Acad Child Psychiatry 1995; 34: 499-509.
13. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 1998; 155: 493-8. (Pubitemid 28207444)
14. Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM, et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med 2006; 36: 167-79.
15. Giaconia RM, Reinberg HZ, Silverman AB, Pakiz B, Frost AK, Cohen E. Age on onset of psychiatric disorders in a community population of older adolescents. J Am Acad Child Psychiatry 1994; 33: 706-17.
16. McCrone P, Knapp M, Fombonne E. The Maudsley long-term follow-up of child and adolescent depression: predicting costs in adulthood. Eur Child Adolesc Psychiatry 2005; 14: 407-13.
17. Bodden DH, Dirksen CD, Bögels SM. Societal burden of clinically anxious youth referred for treatment: a cost-of-illness study. J Abnorm Child Psychol 2008; 36: 487-97.
18. Leibson CL, Long KH. Economic implications of attention-deficit hyperactivity disorder for healthcare systems. Pharmacoeconomics 2003; 21: 1239-62.
19. Matza LS, Secnik K, Rentz AM, Mannix S, Sallee FR, Gilbert D, et al. Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report. Qual Life Res 2005; 14: 735-47. (Pubitemid 40576859)
20. Petrou S, Kupek E. Estimating preference-based Health Utilities Index Mark 3 utility scores for childhood conditions in England and Scotland. Med Decis Making 2009; 29: 291-303.
21. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR for the EPICure Study Group. Neurologic and developmental disability after extremely preterm birth. New Engl J Med 2000; 343: 378-84.
22. Botting N, Powls A, Cooke R, Marlow N. Attention deficit hyperactivity disorder and other psychiatric outcomes in very low birthweight children at 12 years. J Child Psychol Psychiatry 1997; 38: 931-41.
23. Elgen I, Sommerfelt K, Markestad T. Population based, controlled study of behavioural problems and psychiatric disorders in low birthweight children at 11 years of age. Arch Dis Child Fetal Neonatal Ed 2002; 87: F128-32.
24. Indredavik MS, Vik T, Heyerdahl S, Kulseng S, Fayers P, Brubakk AM. Psychiatric symptoms and disorders in adolescents with low birth weight. Arch Dis Child Fetal Neonatal Ed 2004; 89: F445-50.
25. Johnson S, Hollis C, Kochhar P, Hennessy E, Wolke D, Marlow N. Psychiatric disorders in extremely preterm children: longitudinal finding at age 11 years in the EPICure study. J Am Acad Child Adolesc Psychiatry 2010; 49: 453-63.
26. Marlow N, Wolke D, Bracewell MA, Samara M for the EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. New Engl J Med 2005; 352: 9-19.
27. Johnson S, Hennessy EM, Smith R, Trikic R, Wolke D, Marlow N. Academic attainment and special educational needs in extremely preterm children at 11 years of age: the EPICure Study. Arch Dis Child Fetal Neonatal Ed 2009; 94: F283-9.
28. Goodman R, Ford T, Richards H, Gatward R, Meltzer H. The Development and Well-Being Assessment: description and initial validation of an integrated assessment of child and adolescent psychopathology. J Child Psychol Psychiatry 2000; 41: 645-55.
29. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. World Health Organization, 1992.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) Text Revision (DSM-IV-TR). APA, 2000.
32. Kaufman AS, Kaufman NL. Kaufman Assessment Battery for Children. American Guidance Service, 1983.
33. Wolke D, Ratschinski G, Ohrt B, Riegel K. The cognitive outcome of very preterm infants may be poorer than often reported: an empirical investigation of how methodological issues make a big difference. Eur J Pediatr 1994; 153: 906-15. (Pubitemid 24359849)
34. Allen C, Beecham J. Costing services: ideals and reality. In Costing Community Care: Theory and Practice (eds A Netten, J Beecham): 25-42. Ashgate Publishing, 1993.
35. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. Oxford University Press, 2005.
36. National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. NICE, 2008.
37. Department of Health, England. NHS Reference Costs 2006-07. The Information Centre, Department of Health, 2007.
38. Curtis L. Unit Costs of Health and Social Care. Personal Social Services Research Unit (PSSRU), University of Kent, 2007.
39. Paediatric Formulary Committee. BNF for Children, 2007. BMJ Publishing Group, Pharmaceutical Press, and RCPCH Publications, 2007.
40. Torrance GW, Furlong W, Feeny D, Boyle M. Multi-attribute preference functions: Health Utilities Index. Pharmacoeconomics 1995; 7: 503-20.
41. Eiser C, Morse R. Quality-of-life measures in chronic diseases of childhood. Health Technol Assess 2001; 5: 1-156.
42. Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001; 33: 375-84.
43. Horsman J, Furlong W, Feeny D, Torrance GW. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes 2003; 1: 54.
44. Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, et al. Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Med Care 2002; 40: 113-28.
45. Furlong W, Feeny D, Torrance GW, Goldsmith CH, DePauw S, Zhu Z, et al. Multiplicative Multi-attribute Utility Function for the Health Utilities Index Mark 3 (HUI3) System: A Technical Report. Working Paper 98-11. Centre for Health Economics and Policy Analysis, McMaster University, Canada, 1998.
46. McCabe C, Stevens K, Roberts J, Brazier J. Health state values for the HUI 2 descriptive system: results from a UK survey. Health Econ 2005; 14: 231-44.
47. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res 1999; 8: 3-15.
48. Briggs A, Clark T, Wolstenholme J, Clarke P. Missing . . . presumed at random: cost-analysis of incomplete data. Health Econ 2003; 12: 377-92.
49. Gray A, Wolstenholme J, Wordsworth S, Clarke P. Applied Methods of Cost-Effectiveness Analysis. Oxford University Press, 2010.
50. Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000; 19: 219-36.
51. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford University Press, 2006.
52. Johnson S, Fawke J, Hennessy E, Rowell V, Thomas S, Wolke D, et al. Neurodevelopmental disability through 11 years of age in children born before 26 weeks of gestation. Pediatrics 2009; 124: e249-57.
53. Greene WH. Econometric Analysis, 5th edn. Prentice Hall, 2003.
54. Ungar W. Economic Evaluation in Child Health. Oxford University Press, 2009.
55. To T, Dell S, Dick P, Cicutto L. The burden of illness experienced by young children associated with asthma: a population-based cohort study. J Asthma 2008; 45: 45-9.
56. Thornton J, Lunt M, Ashcroft DM, Baildam E, Foster H, Davidson J, et al. Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis. Rheumatology 2008; 47: 985-90.
57. Drummond M. Introducing economic and quality of life measurements into clinical studies. Ann Med 2001; 33: 344-9.
58. Feeny D, Furlong W, Saigal S, Sun J. Comparing directly measured standard gamble scores to HUI2 and HUI3 utility scores: group- and individual-level comparisons. Soc Sci Med 2004; 58: 799-809.
59. Green H, McGinnity A, Meltzer H, Ford T, Goodman R. Mental Health of Children and Young People in Great Britain, 2004. Office for National Statistics, 2004.
60. McClellan J, Bresnahan MA, Echeverria D, Knox SS, Susser E. Approaches to psychiatric assessment in epidemiological studies of children. J Epidemiol Community Health 2009; 63: i4-i14.
61. Petrou S, Murray L, Cooper P, Davidson LL. The accuracy of self-reported health care resource utilization in health economic studies. Int J Technol Assess Health Care 2002; 18: 705-10.
62. Petrou S. Methodological issues raised by preference-based approaches to measuring the health status of children. Health Econ 2003; 12: 697-702. (Pubitemid 37045311)
63. Verrips GHW, Stuifbergen MC, den Ouden LA, Bonsel GJ, Gemke RJ, Paneth N, et al. Measuring health status using the Health Utility Index: agreement between raters and between modalities of administration. J Clin Epidemiol 2001; 54: 475-81.
64. Eiser C, Morse R. Quality-of-life measures in chronic diseases of childhood. Health Technol Assess 2001; 5: 1-156.